Provide robust evidence on the real-world value of treatments to transform healthcare
Promote relative effectiveness, build strategic partnerships, and bring therapies to market â€“ Case Studies from Tehseen Salimi - VP of Global Value & Evidence Development at Sanofi, David Memel - VP of HEOR at Boehringer Ingelheim, Marc Berger - VP of Real World Data & Analytics at Pfizer & Brian Bradbury â€“ Director, Center for Observational Research at Amgen
VP Global Evidence and Value Development
VP â€“ HEOR
VP Real World Data & Analytics
Vice President of Commercial Model Innovation
Pfizer, Primary Care Business Unit
Enhance your payer relationships by meeting them in person.Â Leaders you’ll meet include the EVP/CCO of United Healthcare, Sam Ho M.D.; Stephen B. Bonner, President and CEO, Cancer Treatment Centers of America; Steve Chick, Market Vice President at Humana & Lucius F. Wright M.D., Nephrologist, The Jackson Clinic
|Sam Ho M.D.
Executive Vice President & Chief Medical Officer
|Stephen B. Bonner
President and CEO
Cancer Treatment Centers of America
Market Vice President
|Lucius F. Wright M.D.
The Jackson Clinic
Policy changes can critically effect your evidence generation investments. Meet D.C. insiders - an advisor to the Senate Health Committee speaks on the release of Medicare and Medicaid claims data, commercialization and path to market success. Also hear an exclusive case study industry perspective from Johnson & Johnson Senior Director â€“ Health Policy, Robert Donnelly.
|Dr. Robert Kaplan
Director - Office of Behavioral and Social Sciences Research (OBSSR)
National Institutes of Health
Health Policy Advisor
United States Senate - Health Committee
Senior Medical Officer
HHS - ASPE
Senior Director, Health Policy
Johnson & Johnson
Discover treasure troves of Provider/ACO data-sets to understand why they are interested in collaborating with pharma on the evidence generated about the real-world effects of medical treatments â€“ from Brian Wells, AVP at Penn Medicine, John Lynch, Executive Director at CT Center for Primary Care & Mohit Kaushal, Partner at Aberdare Ventures (ex-CSO at West Health)
AVP Health Technology and Academic Computing
University of Pennsylvania Health Syste
CT Center for Primary Care
|Mohit Kaushal, MD
(Formerly Chief Strategy Officer & EVP at West Health)
Head of Access to External Data
Janssen Pharmaceuticals (a Johnson & Johnson company)
Understand the real-world data opportunities and challenges in emerging markets in Asia and globally from Joe DiCesare, VP Global HEOR at Novartis & Jason Liu, Global Head HEOR at Pfizer.
Network with solution providers that have the insights, tools, technologies and industry knowledge to transform your data into actionable evidence.
Numerof & Associates
|William H. Crown, Ph.D.
Chief Scientific Officer
(President of ISPOR)
Vice President, Global Health Economics & Outcomes Research
Director, Health Industries Advisory, Business Intelligence and Analytics
Don’t just take our word for it…
The expertise of the various speakers and the relevance of the discussion topics made the conference worthwhile and an opportunity for learning.
Brian Bradbury, Director - Center for Observational Research, Amgen
What set this particular meeting apart from others I have attended was the quality of the panel discussions, both in terms of the experience and expertise of the speakers as well as content.
Clark Paramore, Senior Research Scientist - Health Economics, UBC
“A good networking & learning opportunity on topics essential for healthcare improvement. This meeting has global experts willing to share the spirit of open innovation. The panel discussions offer valuable insights with relevant and pragmatic content.”
Tehseen Salimi, VP Global Evidence and Value Development, Sanofi
From what I can see, the 2013 program stands head and shoulders above the more recent entrants to this area. It’s the variety of content, delivery and senior level attendance that I’m most excited about.
Mike Rea, Partner, IDEA Pharma
Why Real World Evidence 2013 is a must attend...
- Case Studies You Need to Hear: From Sanofi, Amgen, Pfizer, Northeastern, Tufts, NIH, Penn Health, and Johnson & Johnson
- Understand the risks of not adapting to disruptions that real world data have created for your business
- Look into the future and learn why building a strategy for data access, collection, and integration will be the basis for your value story
- Make a Case for Market Access: Take action, partner with payers, providers, and vendors to link your value chain and transform raw data into evidence
- Build a strategy for expanding RWE operations in emerging markets like China
- Know the laws on data access and privacy by learning from legal experts
- Use Statistics for Success: and think about how CER, observational studies, retrospective studies, and prospective studies are best conducted